Orphan CNS therapy developer Minoryx Therapeutics closed a $54.8m series C and MIT's The Engine co-led a $10.5m seed round for Foundation Alloy.
Minoryx Therapeutics, a Spain-based developer of treatments for orphan central nervous system disorders, completed a €51m ($54.8m) series C round yesterday that included an undisclosed amount of debt. The round was co-led by Columbus Venture Partners and Caixa Capital Risc, while CDTI, Fund+, Ysios Capital and other unnamed backers also took part. Minoryx was co-founded by Joan Aymamí, a researcher at Universitat Politècnica de Catalunya, and also exploits research undertaken at University of Barcelona by chief executive Marc Martinell. Minoryx’s…
Thierry Heles
Thierry Heles is editor-at-large of Global University Venturing and Global Corporate Venturing, and host of the Beyond the Breakthrough podcast.
